Intense focus of Alveolar Echinococcosis, South Kyrgyzstan by Bebezov, Bakhadyr et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Intense focus of Alveolar Echinococcosis, South Kyrgyzstan
Bebezov, Bakhadyr; Mamashev, Nurlan; Umetaliev, Tilek; Ziadinov, Iskender; Craig, Philip S; Joekel,
Deborah E; Deplazes, Peter; Grimm, Felix; Torgerson, Paul R
Abstract: Human alveolar echinococcosis (AE) is a highly pathogenic zoonotic parasitic disease caused by
Echinococcus multilocularis. An ultrasound study in southern Kyrgyzstan during 2012 revealed a preva-
lence of 4.2% probable or confirmed AE and an additional 2.2% possible AE, representing an emerging
situation. The risk for probable or confirmed AE was significantly higher in dog owners.
DOI: https://doi.org/10.3201/eid2406.161641
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-151701
Published Version
Originally published at:
Bebezov, Bakhadyr; Mamashev, Nurlan; Umetaliev, Tilek; Ziadinov, Iskender; Craig, Philip S; Joekel,
Deborah E; Deplazes, Peter; Grimm, Felix; Torgerson, Paul R (2018). Intense focus of Alveolar Echinococ-
cosis, South Kyrgyzstan. Emerging Infectious Diseases, 24(6):1119-1122.
DOI: https://doi.org/10.3201/eid2406.161641
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 24, No. 6, June 2018 1119
Bakhadyr Bebezov, Nurlan Mamashev,  
Tilek Umetaliev, Iskender Ziadinov,  
Philip S. Craig, Deborah E. Joekel,  
Peter Deplazes, Felix Grimm, Paul R. Torgerson
Human alveolar echinococcosis (AE) is a highly pathogenic 
zoonotic parasitic disease caused by Echinococcus multi-
locularis. An ultrasound study in southern Kyrgyzstan dur-
ing 2012 revealed a prevalence of 4.2% probable or con-
firmed AE and an additional 2.2% possible AE, representing 
an emerging situation. The risk for probable or confirmed 
AE was significantly higher in dog owners.
Human alveolar echinococcosis (AE), caused by the lar-val stage of Echinococcus multilocularis, is a lethal 
parasitic zoonosis if untreated (1,2). In China, hyperen-
demic foci of disease have been described (3) with preva-
lences >5%. AE incidence recently has increased in Europe 
(4). In Kyrgyzstan, the disease incidence has increased rap-
idly since 2000; a total of 148 AE cases were reported in 
2013 (5).
Hospital records for AE notifications identified a clus-
ter of cases in the Alay Valley in southern Kyrgyzstan. 
Therefore, in 2012, we conducted an ultrasound study of 
the population of Sary Mogol (location 39.66°N, 72.88°E) 
to determine the extent of infection and to investigate the 
epidemiology of the disease in this district. 
The Study
The study was a census type of design. We obtained in-
formed consent from each study participant or, for children, 
consent from parents. Participants were interviewed using a 
questionnaire in Kyrgyz and given an abdominal ultrasound 
examination. For participants with hepatic lesions suspected 
to be AE or cystic echinococcosis (CE) or who reported pre-
vious treatment for echinococcosis, a venous blood sample 
was taken for further analysis. The Ministry of Health of the 
Kyrgyz Republic provided ethics approval for this study.
We detected specific IgG from collected serum in 3 ge-
nus-specific ELISAs based on E. granulosus hydatid fluid, 
native protoscolex antigens, and antigen B (6). Specific an-
tibodies against E. multilocularis were demonstrated using 
affinity purified Em2G11 antigen (6) and the recombinant 
Em18 antigen (7). We further investigated persons who 
were negative in these ELISAs with a commercial Western 
blot (Echinococcus western blot IgG; LDBio Diagnostics, 
Lyon, France).
Where possible, we followed participants to treat-
ment. For some patients we obtained samples from resect-
ed lesions. DNA was isolated, followed by amplification 
of part of the E. multilocularis mitochondrial 12S rRNA 
gene (8). Confirmation of diagnosis was also achieved 
by histologic examination of the resected lesions. Pos-
sible AE cases were those with ultrasound lesions and no 
follow-up. Probable cases additionally had positive sero-
logic results, and confirmed cases were positive by histol-
ogy, PCR, or both.
We analyzed data with all AE cases and with probable or 
confirmed AE as the dependent variable using a relative risk 
generalized linear model (GLM). We analyzed differences in 
lesion sizes between seropositive and seronegative groups by 
the Wilcoxon test and used Fisher exact test to examine dif-
ferences in seroprevalence between persons with confirmed 
AE and persons with only an ultrasound diagnosis.
We examined 1,617 persons (Figure 1) (48% of the pop-
ulation of the district; online Technical Appendix, https://
wwwnc.cdc.gov/EID/article/24/6/16-1641-Techapp1.pdf). 
Of these, 106 persons had ultrasound findings consistent with 
AE (including 1 concomitantly infected with CE). Probable 
or confirmed cases (online Technical Appendix) with >2 
diagnostic criteria (Figure 1) were subsequently diagnosed 
in 68 (4.2%) persons leaving 36 (2.2%) with possible AE. 
Three (0.2%) additional persons had lesions suggestive of 
CE. For 9 persons, images were recorded as inconclusive.
The GLM demonstrated an increase in the risk for pos-
sible infection with AE in dog owners, male patients, and 
persons who practiced home slaughter of livestock. Only 
dog ownership increased the risk for probable AE infection 
(Table 1).
Of the 106 persons in whom AE was diagnosed, 
we detected specific antibodies in 40 (42.1%) of the 95 
available serum samples by 3 different ELISAs (Table 2). 
Western blot analysis of negative serum identified specific 
antibodies on Echinococcus genus level in 9 additional pa-
tients. Thus, 49 of the 95 persons had serologic evidence 
of infection. Lesions, measured in 53 patients, ranged from 
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5 to 197 mm (mean 28 mm). The mean size of lesions in 
the 22 ELISA- or Western blot–seropositive persons was 
46.1 mm, significantly larger than the mean size of 11.0 
mm for lesions from the 27 seronegative patients (p = 0.01; 
Figure 2).
By September 2017, a total of 39 persons were known 
to have been treated by hepatic surgery. Among them, AE 
was confirmed in 37 (94.7%) by histology, PCR, or both. 
From these 37 persons, 35 serum samples were available; 
18 (51.4%) showed serologic evidence of infection. This 
finding did not differ significantly from the proportion of 
persons without follow-up data who had serologic evidence 
of infection (31/61) (Figure 1).
The decreasing risk for possible AE with increasing 
age, contrasting with findings in areas of China where 
AE is highly endemic (9), indicates different dynamics 
and hence reflect an emerging epidemic of human AE in 
Kyrgyzstan. Consequently, this observation supports the 
hypothesis that the epidemic could be linked to the dis-
solution of the Soviet Union in 1991 (5). In our study, 
the higher risk for possible AE in male than in female pa-
tients contrasts with risk in areas of western China where 
AE is endemic. The reasons for this difference are unclear 
but might reflect behavioral (e.g., rates of dog contact) or 
cultural reasons that result in a greater risk for exposure 
for female persons in China (9) and for male persons in 
Kyrgyzstan. However, both risk factors disappear if only 
probable or confirmed AE is used as the case definition 
for AE.
The poorer sensitivity (≈50%–60%) of the sero-
logic tests as compared with the validations in Switzer-
land (6) might result from cases in Switzerland being 
Figure 1. Flowchart of patient selection, 
ultrasound investigation, serologic testing, 
and case definitions in a study of AE, 
southern Kyrgyzstan, 2012. AE, alveolar 
echinococcosis; WB, Western blot.
 
Table 1. Relative risk from multivariable analysis of persons with an ultrasound diagnosis of AE and persons with a probable or a 
confirmed diagnosis of AE, southern Kyrgyzstan, 2012* 
Dependent variable, risk factor Relative risk (95% CI) p value 
Ultrasound diagnosis of AE   
Patient age† 0.982 (0.969–0.995) 0.0074 
Male sex 1.56 (1.07–2.29) 0.021 
Dog ownership 1.82 (1.24–2.72) 0.0025 
Home slaughter of livestock 1.60 (1.03–2.56) 0.043 
Dog ownership among persons with probable and confirmed AE‡ 2.81 (1.64–5.09) 0.00033 
*Probable diagnosis: ultrasound and serology; confirmed diagnosis: ultrasound and histology/PCR. AE, alveolar echinococcosis. 
†Median age of persons with possible AE was 24 y; median age of AE-negative persons was 28 y. 
‡Dog ownership was the only risk factor remaining as significant when only probable and confirmed AE were analyzed as the dependent variables. 
 
Alveolar Echinococcosis, Kyrgyzstan
at a more advanced stage of clinical disease. The fact 
that persons with larger lesions were more likely to be 
seropositive indicates that seroconversion might not oc-
cur either during the early stages of the disease or when 
only abortive lesions are present. Similar patterns of low 
seroreactivity were observed in the AE endemic focus 
in south Gansu (China) (10) and included persons with 
possible abortive forms of the disease. In addition, the 
mean age of ultrasound-positive persons in our study 
is 9 years younger than those receiving surgical treat-
ment resulting from clinical disease, indicating that our 
study has detected an early stage of the disease in these 
persons. In the patients followed up, the seropositivity 
rate for those with AE confirmed by histopathology did 
not differ significantly from the rate for those with only 
an ultrasound diagnosis. Thus, we can conclude that the 
same proportion of patients without histologic or PCR 
confirmation (to date) are likely to have AE. Although the 
diagnostic efficiency of ultrasound should be estimated 
with caution, these results might indicate a specificity as 
high as 99.7% (online Technical Appendix). However, 
including only probable or confirmed cases in the regres-
sion analysis increased the association with dog owner-
ship while eliminating other risk factors. This finding 
might indicate that some of the possible AE cases are not 
AE. Nevertheless, specificity of ultrasound in this scenar-
io remains at 97.4%.
Conclusions
We documented a highly endemic focus of human AE in 
which the prevalence of confirmed or probable AE was 
≈4.2% in southern Kyrgyzstan. A characteristic of com-
munities with high levels of human AE are concomitant 
high prevalences of E. multilocularis in the dog population, 
such as western Sichuan Province (11). The mole vole (El-
lobius tancrei) has recently been confirmed as a natural in-
termediate host of E. multilocularis in Sary Mogol and has 
identical DNA sequence for the E. multilocularis haplotype 
described in feces of local domestic dogs (12). In Kyrgyz-
stan, prevalences in dogs of 20% have been observed (13). 
In our study, dog owners had 1.8 times higher risk for in-
fection than non–dog owners, increasing to 3.3 times for 
confirmed or probable infection, thus providing evidence 
that dogs are involved in transmission to humans.
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Table 2. Ultrasound results partially confirmed with PCR/histology for AE or CE in relation to serology, southern Kyrgyzstan, 2012* 
Ultrasound results 
ELISA 
 
WB† 
No. available 
samples‡ Neg AE/CE§ AE¶ 
No. available 
samples‡ Neg AE/CE CE AE 
AE, n = 106 95 55 25 15  43 34 6 3 0 
Confirmed AE,# n = 37 33 18 10 5  13 10 3 0 0 
Inconclusive, n = 9 6 5 1 0  4 4 0 0 0 
CE, n = 3 3 2 1 0  0 0 0 0 0 
CE and AE, n = 1 1 0 1 0  0 0 0 0 0 
Negative but with history of CE/AE, n = 13 6 1 3 2  1 1 0 0 0 
*AE/CE indicates the test is specific only to genus level. AE, alveolar echinococcosis; CE, cystic echinococcosis; neg, negative; WB, Western blot.  
†ELISA-negative serum only. 
‡Not every patient for whom echinococcosis was diagnosed by ultrasound had inconclusive results or a history of echinococcosis provided a blood 
sample. For some of these patients, insufficient serum was available from the blood sample to undertake both ELISA and WB. 
§E. granulosus hydatid fluid and/or native protoscolex antigens and/or antigen B positive but Em18 and EmG11 negative. 
¶Em18 and/or EmG11 positive (E. granulosus hydatid fluid and/or native protoscolex antigens and/or antigen B positive or negative). 
#Diagnosis confirmed by PCR and/or histology of resected lesion. 
 
Figure 2. Differences in sizes of lesions (n = 49 serum samples 
available from 57 patients with measured lesions) diagnosed in 
persons seropositive by ELISA, Western blot, or both (n = 27) 
or seronegative (n = 22) in a study of alveolar echinococcosis, 
southern Kyrgyzstan, 2012. Box plots indicate interquartile range 
(box top and bottom), median (black horizontal line), 1.5 times 
interquartile range (error bars), and extreme values (circles).
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Food Safety
Foodborne illness (sometimes called “food-
borne disease,” “foodborne infection,” or 
“food poisoning”) is a common, costly—yet 
preventable—public health problem. Each 
year, 1 in 6 Americans gets sick by consum-
ing contaminated foods or beverages. Many 
different disease-causing microbes, or patho-
gens, can contaminate foods, so there are 
many different foodborne infections. In addi-
tion, poisonous chemicals, or other harmful 
substances can cause foodborne diseases if 
they are present in food.
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